ReviewBMC cancer2022
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials.
Michael J Grayling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it